8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.28%
Revenue growth under 50% of 2127.T's 27.93%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.84%
Gross profit growth under 50% of 2127.T's 52.27%. Michael Burry would be concerned about a severe competitive disadvantage.
-5.56%
Negative EBIT growth while 2127.T is at 107.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.34%
Operating income growth under 50% of 2127.T's 106.82%. Michael Burry would be concerned about deeper cost or sales issues.
-15.18%
Negative net income growth while 2127.T stands at 150.83%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.18%
Negative EPS growth while 2127.T is at 150.59%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.18%
Negative diluted EPS growth while 2127.T is at 145.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 2127.T's 0.03%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
48.93%
10Y revenue/share CAGR under 50% of 2127.T's 476.90%. Michael Burry would suspect a lasting competitive disadvantage.
63.76%
5Y revenue/share CAGR under 50% of 2127.T's 192.34%. Michael Burry would suspect a significant competitive gap or product weakness.
39.15%
3Y revenue/share CAGR at 50-75% of 2127.T's 71.12%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
80.40%
Below 50% of 2127.T's 561.75%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
56.52%
Below 50% of 2127.T's 232.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
44.96%
3Y net income/share CAGR 50-75% of 2127.T's 67.87%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
137.78%
5Y equity/share CAGR at 75-90% of 2127.T's 157.11%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
66.52%
3Y equity/share CAGR 1.25-1.5x 2127.T's 57.77%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.55%
Firm’s AR is declining while 2127.T shows 476.97%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.93%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.74%
Positive asset growth while 2127.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.67%
BV/share growth above 1.5x 2127.T's 0.34%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-38.23%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
102.83%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.